Диссертация (1139499), страница 45
Текст из файла (страница 45)
Higashi Y. Circadian variation of blood pressure and endothelial function inpatients with essential hypertension: a comparison of dippers and non-dippers./ HigashiY. [at al.] //J Am Coll Cardiol. – 2002. – Vol.40(11). – P.2039-43306. Higashino H. Serum nitric oxide metabolite (NO(x)) levels in hypertensivepatients at rest: a comparison of age, gender, blood pressure and complications usingnormotensive controls./ Higashino H.
[et al]// Clin Exp Pharmacol Physiol. – 2007. –Vol.34(8). – P.725-31.284307. Hilawe EH. Differences by sex in the prevalence of diabetes mellitus, impairedfasting glycaemia and impaired glucose tolerance in sub-Saharan Africa: a systematicreview and meta-analysis./ Hilawe EH. [et al].// Bull World Health Organ. – 2013. –Vol.91(9). – P.671-682D.308. Hochman JS. Sex, Clinical Presentation, And Outcome in Patients with AcuteCoronary Syndromes./ Hochman JS.
[et al]// N Eng J Med. – 1999. – Vol.341. – P.226–232.309. Hoieggen A. The impact of serum uric acid on cardiovascular outcomes in theLIFE study./ Hoieggen A. [et al].// Kidney Int. – 2004. – Vol.65. – P.1041–9.310. Hong H.-J. Suppression of the development of hypertension by the inhibitor ofinducible nitric oxide synthase./ Hong H.-J, Loh S.-H.,Yen M.-H.// Br J Pharmacol. –2000. – Vol.131. – P.631-637.311. Hosseinpanah F.
Prognostic impact of different definitions of metabolicsyndrome in predicting cardiovascular events in a cohort of non-diabetic Tehranian./Hosseinpanah F.[et al]// Int J Cardiol. – 2013. – Vol.168(1). – P.369-74.312. Hotta K. Circulating concentrations of the adipocyte protein adiponectin aredecreased in parallel with reduced insulin sensitivity during the progression to type 2diabetes in rhesus monkeys./ Hotta K. [et al]// Diabetes.
– 2001. – Vol.50. – P.1126–33.313. Howard BV. Women's Health Initiative. Risk of cardiovascular disease byhysterectomy status, with and without oophorectomy: the Women's Health InitiativeObservational Study./ Howard BV [et al]// Circulation. – 2005. – Vol.111(12). –P.1462-70.314. Hsia J. Usefulness of prior hysterectomy as an independent predictor ofFramingham risk score (The Women’s Health Initiative)/ Hsia J. [et al]// Am J Cardiol.– 2003. – Vol.92(3).
– P.264-9.315. Huang PL. eNOS, metabolic syndrome and cardiovascular disease./ Huang PL. //Trends Endocrinol Metab. – 2009. – Vol.20(6). – P.295–302.316. Hunt B.E. Estrogen replacement therapy improves baroreflex regulation ofvascular sympathetic outflow in postmenopausal women./ Hunt B.E. [et al]//Circulation. - 2001. – Vol.103.
– P.2909–2914.285317. Huxley VH. Cardiovascular sex differences influencing microvascular exchange./Huxley VH, Wang J. // Cardiovasc Res. – 2010. – Vol.87. –P.230-242.318. Huxley VH. Sex and the cardiovascular system: the intriguing tale of how womenand men regulate cardiovascular function differently./ Huxley VH.// Adv Physiol Educ.– 2007. – Vol.31. – P.17-22.319. Iida M.
Predictive value of von Willebrand factor for adverse clinical outcome inhypertensive patients with mild-to-moderate aortic regurgitation./ Iida M [et al] // JHum Hypertens.- 2008.- Vol.22.- Р.275-81.320. IL Williams. Obesity, atherosclerosis and the vascular endothelium: mechanismsof reduced nitric oxide bioavailability in obese humans/ IL Williams [et al]//Int JObesity. – 2002. – Vol.26.
– P.754–764.321. Ingelsson E. Hysterectomy and risk of cardiovascular disease: a population-basedcohort study./ Ingelsson E. [et al]// Eur Heart J. – 2011. – Vol.32. – P.745–50.322. Institute of Medicine. Women’s Health Research Progress// Pitfalls, and Promise.- 2010. Available at: http://www.iom.edu/Reports/ 2010/Womens-Health-ResearchProgress-Pitfalls-and-Promise.aspx.323. Intapad S. Sex Differences in the Developmental Origins of CardiovascularDisease./ Intapad S [et al]// Physiology.
– 2014. - Vol. 29. – P.122-132324. Intengan HD. Structure and mechanical proper- ties of resistance arteries inhypertension: role of adhesion molecules and extracellular matrix determinants./Intengan HD, Schiffrin EL. // Hypertension. – 2000. – Vol.36. – P.312-318.325. Jacoby VL. Oophorectomy vs ovarian conservation with hysterectomy:cardiovascular disease, hip fracture, and cancer in the Women’s Health InitiativeObservational Study./ Jacoby VL. [et al]// Arch Intern Med. – 2011. – Vol.171.
–P.760–8.326. Jalil JE. Fibrillar collagen and myocardial stiffness in the intact hypertrophied ratleft ventricle/ Jalil JE. [et al]// Circ. Res. – 1989. – Vol. 64. – P.1041-1050.327. James GD. Renin Relationship to Sex, Race and Age in NormotensivePopulation./James GD. [et al]// J Hypertens. – 1986. – Vol.4 (Suppl 5). – P.S387-9.286328. Janssen I. Menopause and the Metabolic Syndrome. The Study of Women’sHealth Across the Nation/ Janssen I. [et al] // Arch Intern Med. - 2008. – Vol.168(14).
–P.1568-1575.329. Janssen I. Testosterone and Visceral Fat in Midlife Women: The Study ofWomen's Health Across the Nation (SWAN) Fat Patterning Study./ Janssen I. [et al]//Obesity. – 2010. – Vol.18. – P.604–10.330. Jansson JH. Predictive value of tissue plasminogen activator mass concentrationon long-term mortality in patients with coronary artery disease: a 7-year follow-up./Jansson JH, Olofsson BO, Nilsson TK.// Circulation. – 1993. –Vol.88.
– P.2030-2034331. Jensen-Urstad K. Gender difference in age-related changes in vascularfunction/Jensen-Urstad K, Johansson J//J Intern Med. – 2001. – Vol.250. – P.29–36.332. Jia W. Epidemiological study on obesity and its comorbidities in urban Chineseolder than 20 years of age in Shanghai, China/ Jia W. [et al] // Int Ass Study of Obesity.- 2002. – Vol.3. – P.157-65.333. Jiroutek M.R. Changes in Reproductive Hormones and Sex Hormone-BindingGlobulin in a Group of Postmenopausal Women Measured Over 10 Years/ JiroutekM.R.
[et al]// Menopause 1998. - Vol.5. - P.90-94.334. Journatha G. for the Hyper-Q Study Group Sweden. Sex differences in risk factorcontrol of treated hypertensives: a national primary healthcare-based study in Sweden./Journatha G [et al]// Eur J Cardiovasс Prev Rehab. – 2008. – Vol.15. – P.258–262.335. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation,classification, and stratification./National Kidney Foundation.// Am J Kidney Dis. 2002. – Vol.39(2 Suppl 1).
– P.S1-266.336. Kalish M.K. Association of endogenous sex hormones and insulin resistanceamong postmenopausal women: results from the postmenopausal estrogen/progestinintervention trial./ Kalish M.K. [et al]// J Clin Endocrinol. Metab. – 2003. – Vol.88(4). –P.1646-52.337. Kalyani R.R.
Androgen deficiency, diabetes, and the metabolic syndrome inmen./ Kalyani R.R., Dobs A.S.// Curr Opin Endocrinol Diabetes Obes. – 2007. –Vol.14.– P.226–234.287338. Kannel W.B. Left ventricular hypertrophy as a risk factor: the Framinghamexperience./ Kannel W.B. // J Hypertens. – 1991. – Vol.9(Suppl 2). - P.S3-S9.339.
Kannel W.B. The Framingham Study: historical insight on the impact ofcardiovascular risk factors in men versus women./ Kannel W.B. // J Gend Specif Med.– 2002. – Vol.5(2). – P.27-37.340. Kaplan N.M. The deadly quartet: upper-body obesity, glucose intolerance,hypertriglyceridemia and hypertension./ Kaplan N.M. // Arch Intern Med. – 1989. –Vol.149. – P.1514-20.341. Karpanou E.A. Ambulatory blood pressure changes in the menstrual cycle ofhypertensive women./ Karpanou E.A. [et al]// Am J Hypertens. – 1993. – Vol.6. –P.654-659.342. Karpanou E.A. The influence of progressive or abrupt decrease of sex hormoneson lipids in hypertensive women/ Karpanou E.A.
[et al]// Am J Hypertens. – 1995. Vol. 8(4) - P.147A.343. Kassab S. Renal denervation attenuates the sodium retention and hypertensionassociated with obesity/ Kassab S. [et al] // Hypertension. – 1995. – Vol.25(Pt 2). –P.893-897.344. Katholi RE. Hypertensive heart disease syndrome in women in a cardiologypractice./ Katholi RE, Ervin MR, Ginsburg G.// Comprehensive Therapy. – 1997. –Vol.
23(8) – P.508–513.345. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management ofChronic Kidney Disease// Kidney Int Suppl. – 2013. – Vol.3(1).346. Kenemans P. HRT, cardio-protection and the PEPI study./ Kenemans P. // EurMenopause J. - 1995. - Vol.2. - №2.
- P.3.347. Kielstein JT. Asymmetric dimethylarginine, blood pressure, and renal perfusionin elderly subjects./ Kielstein JT [et al]// Circulation. – 2003. – Vol.107. – P.1891-1895348. Kim JA. The prevalence and risk factors associated with isolated untreatedsystolic hypertension in Korea: the Korean National Health and Nutrition Survey./ KimJA [et al]// J Human Hypertens. – 2007. – Vol.21. – P.107-13.288349.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
